These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19586609)

  • 1. Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.
    Nuche-Berenguer B; Moreno P; Portal-Nuñez S; Dapía S; Esbrit P; Villanueva-Peñacarrillo ML
    Regul Pept; 2010 Jan; 159(1-3):61-6. PubMed ID: 19586609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states.
    Nuche-Berenguer B; Moreno P; Esbrit P; Dapía S; Caeiro JR; Cancelas J; Haro-Mora JJ; Villanueva-Peñacarrillo ML
    Calcif Tissue Int; 2009 Jun; 84(6):453-61. PubMed ID: 19219381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
    Moreno P; Nuche-Berenguer B; Gutiérrez-Rojas I; Acitores A; Sancho V; Valverde I; González N; Villanueva-Peñacarrillo ML
    J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia.
    Nuche-Berenguer B; Lozano D; Gutiérrez-Rojas I; Moreno P; Mariñoso ML; Esbrit P; Villanueva-Peñacarrillo ML
    J Endocrinol; 2011 May; 209(2):203-10. PubMed ID: 21372151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation.
    Hie M; Iitsuka N; Otsuka T; Tsukamoto I
    Int J Mol Med; 2011 Sep; 28(3):455-62. PubMed ID: 21567076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats.
    Ma X; Meng J; Jia M; Bi L; Zhou Y; Wang Y; Hu J; He G; Luo X
    J Bone Miner Res; 2013 Jul; 28(7):1641-52. PubMed ID: 23427056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats.
    Candeias E; Sebastião I; Cardoso S; Carvalho C; Santos MS; Oliveira CR; Moreira PI; Duarte AI
    Mol Neurobiol; 2018 May; 55(5):4030-4050. PubMed ID: 28573460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The entero-insular axis: implications for human metabolism.
    Ranganath LR
    Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.
    Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Detroja J; Patel K; Gandhi T; Patel K; Bahekar R; Jain M
    Pharmacol Rep; 2013; 65(4):927-36. PubMed ID: 24145087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CTRP3, a novel adipokine, in rats at different pathogenic stages of type 2 diabetes mellitus and the impacts of GLP-1 receptor agonist on it.
    Li X; Jiang L; Yang M; Wu YW; Sun SX; Sun JZ
    J Diabetes Res; 2014; 2014():398518. PubMed ID: 25177707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status.
    Gutiérrez-Rojas I; Lozano D; Nuche-Berenguer B; Moreno P; Acitores A; Ramos-Álvarez I; Rovira A; Novials A; Martín-Crespo E; Villanueva-Peñacarrillo ML; Esbrit P
    Mol Cell Endocrinol; 2013 Jan; 365(2):309-15. PubMed ID: 23178165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
    Choi HY; Dieckmann M; Herz J; Niemeier A
    PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level.
    Yang Y; Ma D; Xu W; Chen F; Du T; Yue W; Shao S; Yuan G
    Mol Cell Neurosci; 2016 Jan; 70():68-75. PubMed ID: 26640240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in non-diabetic, morbidly obese patients.
    Camastra S; Astiarraga B; Tura A; Frascerra S; Ciociaro D; Mari A; Gastaldelli A; Ferrannini E
    Diabetes Obes Metab; 2017 Mar; 19(3):412-420. PubMed ID: 27898183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel GLP-1/xenin hybrid peptide improves glucose homeostasis, circulating lipids and restores GIP sensitivity in high fat fed mice.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Peptides; 2018 Feb; 100():202-211. PubMed ID: 29412820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.
    Lietzau G; Nyström T; Östenson CG; Darsalia V; Patrone C
    Oncotarget; 2016 Feb; 7(5):5865-76. PubMed ID: 26744321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines.
    Korish AA
    Horm Metab Res; 2014 Jun; 46(6):404-11. PubMed ID: 24627103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
    Gumuslu E; Cine N; Ertan M; Mutlu O; Komsuoglu Celikyurt I; Ulak G
    Fundam Clin Pharmacol; 2018 Apr; 32(2):174-180. PubMed ID: 29091313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.